Addition ally, circadian clock genes, which are regulated by epigenetic mechanisms, have been identified as independent prognostic markers, providing further insight into glioma biology and patient outcomes (Chai et al., 2022). This evidence concerns the gene CLOCK and central nervous system cancer.